Insomnia treatment goes OTC

Modified-release melatonin downscheduled to Pharmacist Only from 1 June Modified-release melatonin has been downscheduled to Schedule 3 (Pharmacist Only) for the treatment of primary insomnia from 1 June 2021. The decision is restricted to short-term monotherapy in people aged 55 or over, with tablets containing 2mg or less in packs up to 30 tablets. Currently

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Webinar: Interaction between the immune system and micronutrients
Next ‘Boundary breaches’ in misconduct case